Angiopoietin 1 expression levels in the myocardium direct coronary vessel development

scientific article published in March 2004

Angiopoietin 1 expression levels in the myocardium direct coronary vessel development is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/DVDY.10479
P8608Fatcat IDrelease_wd4g5axnljgwvccovhgzsfw2d4
P698PubMed publication ID14991706
P5875ResearchGate publication ID5656299

P50authorNicole L. WardQ42131708
P2093author name stringDaniel J Dumont
Paul Van Slyke
Celina Sturk
Maribelle Cruz
P2860cites workThe Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction.Q51715205
Conditional transgene expression in endothelial cells.Q52176912
Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis.Q52214194
Conditional transgene expression in the heartQ71590968
N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesisQ72286021
Increased vascularization in mice overexpressing angiopoietin-1Q77418701
Angiopoietins 3 and 4: diverging gene counterparts in mice and humansQ22008836
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloningQ24310148
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesisQ24313372
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formationQ24316945
The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart developmentQ24605541
Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migrationQ28145912
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesisQ28300359
Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival functionQ28365924
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and functionQ28505330
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1Q28513759
Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryoQ28586040
FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardiumQ28587401
M-cadherin and its sisters in development of striated muscleQ33592129
VEGFs, receptors and angiogenesisQ33644265
Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).Q34032032
Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice.Q34051459
The cadherin-catenin adhesion system in signaling and cancerQ34124023
Cellular interactions in vascular growth and differentiationQ34177719
Eph receptors and ephrin ligands. essential mediators of vascular development.Q34204669
Developmental roles of platelet-derived growth factorsQ34269318
The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesisQ34498133
Vascular patterning by Eph receptor tyrosine kinases and ephrinsQ34611029
Mechanisms of embryonic coronary artery developmentQ34641873
Development of the coronary blood supply: changing concepts and current ideasQ34810697
Development of the coronary vessel systemQ34986182
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac functionQ35895986
P433issue3
P304page(s)500-509
P577publication date2004-03-01
P1433published inDevelopmental DynamicsQ59752
P1476titleAngiopoietin 1 expression levels in the myocardium direct coronary vessel development
P478volume229

Reverse relations

cites work (P2860)
Q35103148Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.
Q51772632Angiopoietin-1 for myocardial angiogenesis: a comparison between delivery strategies.
Q45866244Cell-based angiopoietin-1 gene therapy for acute lung injury.
Q54506625Chapter 9. Development of coronary vessels.
Q37534988Coronary vessel development and insight towards neovascular therapy.
Q35937605Development of coronary vessels
Q36387870Endothelial-cardiomyocyte interactions in cardiac development and repair
Q36081721Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation.
Q24303956Epicardial-myocardial signaling directing coronary vasculogenesis
Q37998444Importance of myocyte-nonmyocyte interactions in cardiac development and disease
Q35909145Niaspan increases axonal remodeling after stroke in type 1 diabetes rats
Q47442360Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies
Q39012408Prospects for improving neovascularization of the ischemic heart: Lessons from development
Q41903030Tbx18 regulates development of the epicardium and coronary vessels.
Q37687321The epicardium as a candidate for heart regeneration.
Q37799410The epicardium in cardiac repair: From the stem cell view
Q36052725The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems.
Q35511977Therapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy
Q92185709Tie2 regulates endocardial sprouting and myocardial trabeculation
Q45250508Vascular-specific growth factor angiopoietin 1 is involved in the organization of neuronal processes

Search more.